Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:52 AM
Ignite Modification Date:
2025-12-25 @ 4:52 AM
NCT ID:
NCT02504918
Eligibility Criteria:
* INCLUSION CRITERIA:
A study participant must satisfy the following criteria to be enrolled in this study:
* A child between 12-59 months
* Parent/guardian able to provide consent
* Resident of the health district of Ouelessebougou or neighboring district for at least a year
EXCLUSION CRITERIA:
* Clinically symptomatic or apparent severe anemia or any other condition that may be worsened by 5 mL phlebotomy or any other study procedure
* Chronic or debilitating condition that precludes attendance for monthly visits
* Known or clinically apparent condition of immunosuppression or chronic infection.
* Known allergies to study treatments (SP; amodiaquine; artemether-lumefantrine)
* Use of cotrimaxozale on a routine basis for prophylaxis
* Conditions that in the judgment of the investigator could increase the risk to the volunteer.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
12 Months
Maximum Age:
59 Months
Study:
NCT02504918
Study Brief:
Protocol Section:
NCT02504918